La Jolla, CA, United States of America

Priya Prakash Karmali

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Priya Prakash Karmali. Retrieved from https://idiyas.com/inventor/priya-prakash-karmali-ync08zpn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Priya Prakash Karmali: Innovator in Cationic Lipopeptides

Introduction

Priya Prakash Karmali is a notable inventor based in La Jolla, California. She has made significant contributions to the field of biotechnology, particularly in the synthesis of novel cationic lipopeptides. Her work focuses on developing innovative solutions for targeting anti-cancer therapies.

Latest Patents

Priya holds 1 patent for her invention, which provides the synthesis of a novel series of cationic lipopeptides with integrin-binding RGD functionalities. This invention also highlights the high L27 cell tropic gene transfer properties of these novel RGD-lipopeptides. The L27 cell surface contains overexpressed integrins, making these lipopeptides promising candidates for targeting anti-cancer genes and drugs to the endothelial cells of tumor vasculatures.

Career Highlights

Priya is affiliated with the Council of Scientific and Industrial Research, where she continues to advance her research in the field. Her innovative work has the potential to impact cancer treatment significantly.

Collaborations

She collaborates with esteemed colleagues such as Bharat Kumar Majeti and Pramanik Dipankar, contributing to a dynamic research environment.

Conclusion

Priya Prakash Karmali is a pioneering inventor whose work in cationic lipopeptides holds promise for future applications in cancer therapy. Her contributions to biotechnology are noteworthy and reflect her commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…